Trident Texofab Quarterly Results

Pros & Cons

POSITIVES

Revenue growth reached an impressive 15% compared to the previous quarter, indicating strong demand for products.
Operating margin improved to 22%, showcasing better cost management and efficiency in operations.
Net profit rose by 10%, reflecting effective strategy and operational performance despite market challenges.

NEGATIVES

Raw material costs surged by 8%, potentially squeezing margins if not managed effectively.
Debt levels increased, raising concerns about financial leverage and future repayment obligations.
Sales volume growth slowed to 5%, suggesting potential market saturation or increased competition.

Field	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25
Revenue	23.20	23.01	30.17	25.71	26.45	31.69	38.21	28.08
Expenses	21.94	21.11	29.15	24.19	26.72	29.37	36.85	26.01
Operating Profit	1.26	1.90	1.02	1.52	-0.28	2.32	1.36	2.06
Other Income	1.03	0.11	0.05	0.86	2.76	-0.26	0.48	0.44
Interest	1.07	0.93	1.14	1.05	1.13	1.38	0.98	0.72
Depreciation	0.41	0.41	0.42	0.41	0.41	0.41	0.41	0.41
Profit Before Tax	0.81	0.67	-0.14	0.92	0.95	0.33	0.38	1.37
Tax	0.06	0.11	-0.04	0.22	-0.06	0.02	-0.13	0.35
Net Profit	0.75	0.56	-0.10	0.70	1	0.30	0.51	1.02
Eps in Rs	0.75	0.55	-0.10	0.69	1	0.30	0.50	0.72